PFG
RPRX icon

Peterson Financial Group’s Royalty Pharma RPRX Stock Holding History

Peterson Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.66K Buy
+200
New +$5.54K 0.02% 280

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Peterson Financial Group's RPRX Position: Q3 2024 in Review

Peterson Financial Group opened a new position in Royalty Pharma (RPRX) in Q3 2024: 200 shares worth $5.66K. The stake represents 0.02% of the portfolio and ranks #280 among its holdings.

395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • Peterson Financial Group held 200 shares of Royalty Pharma worth $5.66K as of Q3 2024.
  • Royalty Pharma was a new Peterson Financial Group position in Q3 2024.
  • Royalty Pharma made up 0.02% of Peterson Financial Group's portfolio in Q3 2024, its #280 holding.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Peterson Financial Group's 13F filing for Q3 2024, filed 6 Nov 2024.